TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: MA for trunk extension/flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom and medication scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: composite complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: dialysis-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: composite adverse obstetrical outcome
Endpoint domain: Adverse events/effects
Primary endpoint: hypertensive disorders of pregnancy
Endpoint domain: Adverse events/effects
Primary endpoint: postprandial glucose increases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Trismus measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity (PA) counts/minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endoscopist satisfaction level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of body movements during the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relaxation levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: throbbing pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Superior displacement measurements of the anterior portion of tibial spine fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of personality status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in personality disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening of personality disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: length-for-age z-score (LAZ) at 18 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MNREAD acuity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ETDRS visual acuity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent with glucose >250 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confirmation rate of IgE-dependent food allergy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TVRE (target vessel revascularization events)
Endpoint domain: Mortality/survival
Primary endpoint: NTVRE (non-target vessel revascularization events)
Endpoint domain: Mortality/survival
Primary endpoint: Publication bias and outcome reporting bias
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of sites with CAL <5 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GCF amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean proportion of sites with PPD reduction >1 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ambulation at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accumulation of visceral fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: android-to-gynoid fat ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: total fat accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: First fit success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uncorrected high-contrast visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with correction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Knowledge of benefits and harms of mammography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowering screening intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: LUSsc reliability in predicting respiratory support mode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: theoretical and technical scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: job stress evaluation scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: professional identity evaluation scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Peak and plateau pressure values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: aerobic endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: exercise self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction in self-reported serves of unhealthy snacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IST response at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: balance and functional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-log reduction in microorganisms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: MFRT changes for sitting balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regulated upon Activation, Normal T‐Cell Expressed and Secreted
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: platelet‐derived growth factor (two B subunits)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: interferon‐inducible protein 10 (IP‐10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Overall self-reported social skills (SSIS)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Overall social skill impairment (SRS)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Parent satisfaction with intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: worsening of eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of overt upper GI bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: time required to manage vascular access
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: technical success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: RVNA geometric mean titers (GMTs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: adhesion score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative adhesion reformation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress level (1-10 scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk factors associated with TB diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Knowledge of complications of pre-eclampsia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: decrease in elbow flexors MVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: decrease in resting evoked twitch forces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: increase in pain scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Concentration of methionine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC of predictive algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in spatially biased attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feeling of hunger
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Principal absorption half-life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapeutic penicillin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak vertical ground reaction force (vGRF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COP medial-lateral (ML) range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COP anterior-posterior (AP) range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New carotid plaque appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiovascular diseases (CVD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean MET score at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Healthy eating value at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cerebral hemodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence rate of intraventricular hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Use of phenylephrine and ephedrine
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Relative risk of Type 2 Diabetes (T2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cronbach's α coefficients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kaiser-Meyer-Olkin value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Root mean square error of approximation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microvascular post-occlusive reactive hyperaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: increased rCBF in the frontal gyrus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rates of reversion from MCI to normal cognition
Endpoint domain: Mortality/survival
Primary endpoint: Tissue thickness around the LAA orifice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biventricular longitudinal strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in management of daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Psoriasis Area and Severity Index ≥90% improvement (PASI 90)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: static Physician Global Assessment (sPGA) 0/1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shoot dry matter production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accumulation of sodium in the shoot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: up-regulation of proteins involved in photosynthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SARS-CoV-2 infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Composite BSF before SBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unplanned additional procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: less blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: briefer hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: lower postoperative white blood cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Locoregional control (LRC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distant metastases-free survival (DMFS)
Endpoint domain: Mortality/survival
Primary endpoint: sensory block time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: degree of motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of PD_manager system
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Detection and evaluation of tremor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' self-rated health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: axon outgrowth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients with ulcerated OM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant behaviors regarding MVP use
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Depressive symptoms relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: EAT reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical quality of images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antral follicle count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of grade 2 stomach
Endpoint domain: Adverse events/effects
Primary endpoint: Renal event rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Screen failure rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: functional efficiency of the affected upper limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nasopharyngeal temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle strength of quadriceps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Muscle strength of hamstrings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Physical function of the knee
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Expiratory duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pressure properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Control of scabies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Application step score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Education and counselling scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in exosomal miRNAs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Implant use by 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Prevalence of common mental disorders (CMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of common mental disorders (CMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of common mental disorders (CMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRV indexes (SDNN, RMSSD, PNN50, TP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in deep subcutaneous adipose tissue (dSAT) volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in visceral adipose tissue (VAT) volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NASH histologic improvement (NAS reduction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevention advocacy
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Improvement in allergic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Organizational citizenship behaviour
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Adherence to DM medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global Rating Scale (GRS) performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: within‐network DMN FC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cortisol concentration 60 minutes after surgical incision
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Propofol requirements for induction
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: inclusion rates of participants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: safe disposal rates of excess opioid medication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: HRQoL improvements
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Prostate cancer progression-related events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: mMASI scores reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: MELASQoL scores reduction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: GAIS improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Withdrawal movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month primary unassisted patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: improvements in patient reported outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: improvements in patient reported outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Water infused during insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global orientation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: spatial orientation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Lund-Mackay Score (LMK)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of approach signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of withdrawal signs
Endpoint domain: Adverse events/effects
Primary endpoint: overall clinical trial accrual
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Age of puberty onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight-for-age z score at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rapid weight gain from birth to 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in non-inflammatory lesion counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment success at week 12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of acute pulmonary edema
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease in ETDQ‐7 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with improvements in tympanometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with improvements in ET inflammation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OCT-based injury score (IS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tissue prolapse (TP) area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BOLUS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in elbow extension angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in forward trunk position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lymph node yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: methylation changes in CpG sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: post-breakfast peak blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: early postprandial glucose AUC0-60 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Width of the third ventricle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CRS-R and GCS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Overtreatment rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Wart free at week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes